Sagari Betté
Sagari Betté publishes mostly in Neurology, Molecular Biology and Psychiatry and Mental health, on topics such as Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments and Botulinum Toxin and Related Neurological Disorders.
- World rank
- #3,291,447 of 7,710,434 ranked researchers
- Rank in United States
- #930,720 of 1,627,098
- Works
- 25
- Citations
- 265
- Citations per work
- 10.6
What does Sagari Betté research?
Sagari Betté's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (7%), Neuroscience (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1768.9%
- Medicine1768.9%
- Everything else417.9%
- Life Sciences313.2%
- 1Neurology56% of their works
- 2Molecular Biology7% of their works
- 3Psychiatry and Mental health7% of their works
- 4Cellular and Molecular Neuroscience7% of their works
- 5Hematology3% of their works
- 6Genetics3% of their works
Research topics
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Botulinum Toxin and Related Neurological Disorders
- Genetic Neurodegenerative Diseases
- Cerebral Palsy and Movement Disorders
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Parkinson's Disease and Spinal Disorders
Which keywords describe Sagari Betté's research?
The keywords of their largest research topics: Parkinson's Disease, Mitochondrial Dysfunction, Neurological Disorders, a-Synuclein, Neurodegeneration, Deep Brain Stimulation, Basal Ganglia and Subthalamic Nucleus.
- Myelofibrosis
- Dropped Head Syndrome
- Acute Myeloid Leukemia
- ICF Model
- Protein Aggregation
- Neurotoxins
- Subthalamic Nucleus
- Deep Brain Stimulation
- Neurodegeneration
- Mitochondrial Dysfunction
- Parkinson's Disease
- Neurological Disorders
- a-Synuclein
- Basal Ganglia
- Botulinum Toxin
- Huntington's Disease
- Cerebral Palsy
- AML
- Camptocormia
- JAK2 Mutation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Parkinson's Disease263 topics
- Mitochondrial Dysfunction192 topics
- Neurological Disorders173 topics
- Neurodegeneration151 topic
- a-Synuclein151 topic
- Deep Brain Stimulation112 topics
- Basal Ganglia91 topic
- Subthalamic Nucleus91 topic
- Botulinum Toxin61 topic
- Neurotoxins61 topic
- Huntington's Disease41 topic
- Protein Aggregation41 topic
- Cerebral Palsy31 topic
- ICF Model31 topic
- AML21 topic
- Acute Myeloid Leukemia21 topic
- Camptocormia21 topic
- Dropped Head Syndrome21 topic
- JAK2 Mutation21 topic
- Myelofibrosis21 topic
Where does Sagari Betté work?
Sagari Betté's main affiliation in the publication record is Parkinson's Research and Education Foundation, United States.
How many publications and citations does Sagari Betté have?
OpenAlex counts 25 works and 265 citations for Sagari Betté, an h-index of 7, ranking #3,291,447 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sagari Betté. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.